Hunting the HIV-1 Unicorn
狩猎 HIV-1 独角兽
基本信息
- 批准号:10343694
- 负责人:
- 金额:$ 92.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-03-01 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:AllelesBiological AssayCallithrixCell Culture TechniquesDrug userFc ReceptorGenesGeneticGenetic VariationGenotypeHIVHIV-1HIV-1 vaccineHumanImmune responseIndividualInfectionIntravenousKnowledgeMacacaMacaca mulattaMacaca nemestrinaModelingMonkeysNeedlesNight MonkeyPapioPathogenesisPrimatesPublic HealthResearchSIVSaimiriT-Cell ReceptorTestingVaccinesVariantVirusbasedrug developmentinfection ratekiller inhibitory receptorknowledge basenonhuman primatetransmission processvaccine development
项目摘要
Project Summary While there are many public health strategies in place for reducing HIV-1 infection rates in drug users, an effective HIV-1 vaccine remains critical to this effort. Studies of HIV-1 transmission, pathogenesis, and vaccine development are mostly conducted in macaque monkeys, although this primate model of HIV-1 infection has many limitations. In the decades since the macaque model was established, we have learned a tremendous amount about the immune response against HIV-1 and SIV. However, this hard-earned knowledge has never been synthesized into an integrated, rational approach for reevaluating the nonhuman primate model for HIV-1 infection. We present a principled approach for re-evaluating the genetic background of different primate species, capitalizing on the enormous knowledge base in the field, and on the substantial genetic diversity that exists. We will genotype restriction factor alleles from thousands of nonhuman primates representing several key primate species (rhesus macaques, pigtailed macaques, owl monkeys, baboons, marmosets, and squirrel monkeys) and test all discovered restriction factor alleles against HIV-1 in cell culture-based assays. Each discovered allele will be given an HIV-compatibility score, allowing systematic and rational determination of which species, and which specific individuals within those species, have restriction factor genotypes most compatible with HIV-1. As part of our approach, we will also evaluate MHC, KIR, and antibody receptor (FcR) gene content and allelic diversity in these primate species. We will specifically test discovered alleles against transmitted/founder (T/F) HIV-1, the variants that an effective vaccine needs to recognize. We will test T/F viruses previously isolated after both sexual and intravenous infection in humans, the two main modes by which drug users acquire HIV-1 infection. Ultimately, our research could open up exciting new avenues in the study of HIV-1 pathogenesis and transmission, and in the development of drugs and vaccines.
项目摘要 虽然已经制定了许多公共卫生策略来降低吸毒者的 HIV-1 感染率,但有效的 HIV-1 疫苗对于这项工作仍然至关重要。 HIV-1 传播、发病机制和疫苗开发的研究大多在猕猴中进行,尽管这种 HIV-1 感染的灵长类动物模型有许多局限性。自猕猴模型建立以来的几十年里,我们已经了解了大量有关针对 HIV-1 和 SIV 的免疫反应的知识。然而,这种来之不易的知识从未被整合成一种综合的、合理的方法来重新评估 HIV-1 感染的非人类灵长类动物模型。我们提出了一种重新评估不同灵长类物种遗传背景的原则性方法,利用该领域庞大的知识库以及现有的大量遗传多样性。我们将对代表几种关键灵长类物种(恒河猴、猪尾猕猴、猫头鹰猴、狒狒、狨猴和松鼠猴)的数千种非人类灵长类动物的限制因子等位基因进行基因分型,并在基于细胞培养的测定中测试所有发现的针对 HIV-1 的限制因子等位基因。每个发现的等位基因都会被给予 HIV 相容性评分,从而可以系统、合理地确定哪些物种以及这些物种中的哪些特定个体具有与 HIV-1 最相容的限制因子基因型。作为我们方法的一部分,我们还将评估这些灵长类动物的 MHC、KIR 和抗体受体 (FcR) 基因含量和等位基因多样性。我们将专门测试已发现的针对传播/创始人 (T/F) HIV-1 的等位基因,这是有效疫苗需要识别的变体。我们将测试之前在人类性行为和静脉注射后分离出的 T/F 病毒,这是吸毒者感染 HIV-1 的两种主要方式。最终,我们的研究可能为 HIV-1 发病机制和传播的研究以及药物和疫苗的开发开辟令人兴奋的新途径。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Saliva TwoStep for rapid detection of asymptomatic SARS-CoV-2 carriers.
- DOI:10.7554/elife.65113
- 发表时间:2021-03-29
- 期刊:
- 影响因子:7.7
- 作者:Yang Q;Meyerson NR;Clark SK;Paige CL;Fattor WT;Gilchrist AR;Barbachano-Guerrero A;Healy BG;Worden-Sapper ER;Wu SS;Muhlrad D;Decker CJ;Saldi TK;Lasda E;Gonzales P;Fink MR;Tat KL;Hager CR;Davis JC;Ozeroff CD;Brisson GR;McQueen MB;Leinwand LA;Parker R;Sawyer SL
- 通讯作者:Sawyer SL
Just 2% of SARS-CoV-2-positive individuals carry 90% of the virus circulating in communities.
- DOI:10.1073/pnas.2104547118
- 发表时间:2021-05-25
- 期刊:
- 影响因子:11.1
- 作者:Yang Q;Saldi TK;Gonzales PK;Lasda E;Decker CJ;Tat KL;Fink MR;Hager CR;Davis JC;Ozeroff CD;Muhlrad D;Clark SK;Fattor WT;Meyerson NR;Paige CL;Gilchrist AR;Barbachano-Guerrero A;Worden-Sapper ER;Wu SS;Brisson GR;McQueen MB;Dowell RD;Leinwand L;Parker R;Sawyer SL
- 通讯作者:Sawyer SL
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sara Sawyer其他文献
Sara Sawyer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sara Sawyer', 18)}}的其他基金
Characterizing Host-Virus Interactions in a New HIV Model Organism
表征新的 HIV 模型生物中的宿主病毒相互作用
- 批准号:
10676334 - 财政年份:2022
- 资助金额:
$ 92.4万 - 项目类别:
Characterizing Host-Virus Interactions in a New HIV Model Organism
表征新的 HIV 模型生物中的宿主病毒相互作用
- 批准号:
10548703 - 财政年份:2022
- 资助金额:
$ 92.4万 - 项目类别:
Rapid evolution of genes critical for genome integrity
对基因组完整性至关重要的基因的快速进化
- 批准号:
8122066 - 财政年份:2010
- 资助金额:
$ 92.4万 - 项目类别:
Rapid evolution of genes critical for genome integrity
对基因组完整性至关重要的基因的快速进化
- 批准号:
7865834 - 财政年份:2010
- 资助金额:
$ 92.4万 - 项目类别:
Rapid evolution of genes critical for genome integrity
对基因组完整性至关重要的基因的快速进化
- 批准号:
8247032 - 财政年份:2010
- 资助金额:
$ 92.4万 - 项目类别:
Rapid evolution of genes critical for genome integrity
对基因组完整性至关重要的基因的快速进化
- 批准号:
9187508 - 财政年份:2010
- 资助金额:
$ 92.4万 - 项目类别:
Rapid evolution of genes critical for genome integrity
对基因组完整性至关重要的基因的快速进化
- 批准号:
8039280 - 财政年份:2010
- 资助金额:
$ 92.4万 - 项目类别:
相似海外基金
Establishment of a new biological assay using Hydra nematocyst deployment
利用水螅刺丝囊部署建立新的生物测定方法
- 批准号:
520728-2017 - 财政年份:2017
- 资助金额:
$ 92.4万 - 项目类别:
University Undergraduate Student Research Awards
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10368760 - 财政年份:2017
- 资助金额:
$ 92.4万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10669539 - 财政年份:2017
- 资助金额:
$ 92.4万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9570142 - 财政年份:2017
- 资助金额:
$ 92.4万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9915803 - 财政年份:2017
- 资助金额:
$ 92.4万 - 项目类别:
COVID-19 Supplemental work: POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER).
COVID-19 补充工作:用于确定组织特异性吸收电离辐射剂量的护理点生物测定(生物剂量计)。
- 批准号:
10259999 - 财政年份:2017
- 资助金额:
$ 92.4万 - 项目类别:
Drug discovery based on a new biological assay system using Yeast knock-out strain collection
基于使用酵母敲除菌株收集的新生物测定系统的药物发现
- 批准号:
21580130 - 财政年份:2009
- 资助金额:
$ 92.4万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2005
- 资助金额:
$ 92.4万 - 项目类别:
Postdoctoral Fellowships
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2004
- 资助金额:
$ 92.4万 - 项目类别:
Postdoctoral Fellowships














{{item.name}}会员




